Summary
Symphogen is a privately-owned biotech company focused on oncology and immuno-oncology.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
Senior Management
Martin Olin
CEO
Bernhard Ehmer
Chairman